VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here : IndiaNotes >> Research & Analysis >> Companies >> Omkar Speciality Chemicals Ltd. >> Research

Omkar Speciality Chemicals: Buy for a target implying an upside of 15% in 1 year

  • Rate this article
    (Average Rating 0.0 Based on 0 ratings)


Valuation Conclusion


Company had embarked on the major capacity expansion to scale up for the existing product lines and launch of new molecules. Additionally, company will continue to tap new geographies, add new customers and increase wallet share with existing customers by offering a wide suite of products.


Company's business segments have contributed to Q3 FY 2017 growth coupled with stress on greater operating efficiencies, would enable company to clock higher profitability in the years ahead.


Company's operations are consistent on account of diversity in various niche products & wide customer base. Moreover, the EBIDTA margins are also reasonably strong and sustainable. Hence the management has decided to make every attempt to reduce the finance cost which can lead to enhanced profitability & EPS.


Company has obtained a patent related to the process for preparation of higher derivatives of Beta Ketoester granted by the Government of India. With this, the total number of patents till date granted to the company stood at 4, this is in line with achieving its goal of higher operating efficiencies, productivity, innovation and process excellence.


Estimating the share price of the company as per P/E valuation, putting the estimated P/E of FY18E at 6x the estimated EPS at Rs28.29, the estimated share price for next 1 year tenure turns around to be Rs180. Therefore, we recommend to BUY this script.


  Read full report Click here to read the full report

logo
BSE
169.00 -4.60
(-2.65%)
NSE
170.40 -2.80
(-1.62%)
Read More
About Rudra Shares and Stock Brokers

RUDRA is one of the growing & dynamic brokerage houses with a strong presence in the Retail and HNI broking segment. With over 25 years of experience and lead by a team with outstanding managerial acumen, RUDRA is a professionally managed company supported by over 100 professionals, including Chartered Accountants, MBAs and other senior executives. RUDRA can thereby cater to its clients' short-term as well as long-term financial needs through a comprehensive bouquet of investment services. RUDRA offers a diverse range of financial services, including institutional and retail brokerage of Equity, Currency, Commodities, Derivatives, Online Trading, Depository Services, Fixed Deposits, IPOs and Mutual Funds Distribution, and Wealth Advisory & Research. RUDRA is looking to become one of the biggest broking houses. RUDRA Securities Limited, is a member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited, MCX Stock Exchange, and Depository Participant of Central Depository Services (I) Limited. RUDRA can be approached online at www.rudrashares.com.

 

For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.




Technical Calls

What are technical calls?

Other Articles


Have a question?

Stalwart Investment Advisors
Stalwart Investment Advisors - Stalwart Investment Advisors